[DOI] [PubMed] Chen J, Zhou H, Jin H, Liu K
Mice were humanely euthanized at week 12 after CS treatment
J Jankovic EK Tan 2020 Parkinsons disease: etiopathogenesis and treatment J Neurol Neurosurg Psychiatry 91 8 795 808 S Jewell AM Herath R Gordon 2022 Inflammasome activation in Parkinsons disease J Parkinsons Dis 12 s1 S113 S128 L Gatta C Scarpignato 2017 Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth Aliment Pharmacol Ther 45 5 604 616 Seo H, Yang C, Kim H-S, Kim K-S (1996) Multiple protein factors interact with the cis-regulatory elements of the proximal promoter in a cell-specific manner and regulate transcription of the dopamine-hydroxylase gene F Garretti C Monahan A Sette D Agalliu D Sulzer 2022 T cells, alpha-synuclein and Parkinson disease Handb Clin Neurol 184 439 455 M Villumsen S Aznar B Pakkenberg T Jess T Brudek 2019 Inflammatory bowel disease increases the risk of Parkinsons disease: a Danish nationwide cohort study 19772014 Gut 68 1 18 24 Y Fu Z Gu H Cao C Zuo Y Huang Y Song Y Jiang F Wang 2024 The role of the gut microbiota in neurodegenerative diseases targeting metabolism Front Neurosci 18 1432659 MJ Benskey RG Perez FP Manfredsson 2016 The contribution of alpha synuclein to neuronal survival and function - implications for Parkinsons disease J Neurochem Ren Y, Wu K, He Y, Zhang H, Ma J, Li C, Ruan Y, Zhang J et al (2024) The role of NLRP3 inflammasome-mediated neuroinflammation in chronic noise-induced impairment of learning and memory ability
Most notably, MIROR-FD was reported a 12-month aneurysm occlusion success rate of 91.41% (117/128) and a complete occlusion rate of 85.94% (110/128) in the multicenter clinical study
The cereblon-based PROTAC 121 , targeting sirtuins (Sirt) histone deacetylases, was shown to selectively degrade and inhibit target activity (IC 50 value of 0.25 M), thereby inducing downstream -tubulin hyperacetylation
